5-Bromo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine, 95.0%, 25g

Methyl 5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylate hydrochloride, 97%, 1g

1-(Trifluoromethyl)cyclopropane-1-carboxylic Acid>98.0%(GC)(T)200mg

4-(4-Pyridyl)-2-[4-(trifluoromethyl)phenyl]-thiazole, 1g

(1S,2R)-1-Phenyl-2-pyrrolidin-1-yl-propan-1-ol, 97.0%, 5g

Diethyl 2-methylenesuccinate (stabilised with TBC), 95.0%, 25g

3-Methyl-1-(pyridin-2-yl)butan-1-amine, 95.0%, 5g

4-(5-Chloromethyl-[1,2,4]oxadiazol-3-yl)-benzoic acid methyl ester, 95.0%, 1g

tert-Butyl 3-(3-cyano-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)azetidine-1-carboxylate, 95.0%, 250mg

Methyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate, 95.0%, 100g

2-(3-Bromophenyl)-1,3,4-oxadiazole, 95+%, 1g

2-(4-Bromo-2-methoxyphenoxy)ethan-1-ol, 95+%, 100mg

8-Hydroxyquinoline-β-D-glucuronic acid sodium salt, 500 mg, >=98%